- Home
- KURA vs AOD Comparison
KURA vs AOD Comparison
Compare KURA & AOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KURA | AOD |
|---|---|---|
| Founded | 2014 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | 2015 | 2006 |
Fundamental Metrics
Financial Performance| Metric | KURA | AOD |
|---|---|---|
| Price | $9.83 | $10.22 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 16 | 0 |
| Target Price | ★ $31.85 | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 373.6K |
| Earning Date | 11-03-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $67,482,000.00 | N/A |
| Revenue This Year | $42.46 | N/A |
| Revenue Next Year | $116.75 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 25.24 | N/A |
| 52 Week Low | $7.36 | $8.76 |
| 52 Week High | $13.90 | $10.85 |
Technical Indicators
Market Signals| Indicator | KURA | AOD |
|---|---|---|
| Relative Strength Index (RSI) | 31.67 | 45.99 |
| Support Level | $8.45 | $9.88 |
| Resistance Level | $11.32 | $10.61 |
| Average True Range (ATR) | 0.42 | 0.16 |
| MACD | -0.06 | 0.01 |
| Stochastic Oscillator | 13.92 | 46.27 |
Price Performance
Historical ComparisonAbout KURA Kura Oncology Inc.
Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.
About AOD abrdn Total Dynamic Dividend Fund of Beneficial Interest
Aberdeen Total Dynamic Dividend Fund is a diversified, closed-end management investment company. Its investment objective is to seek high current dividend income. The company also focuses on the long-term growth of capital as a secondary investment objective. The fund invests in foreign securities, including direct investments in securities of foreign issuers and investments in depositary receipts that represent indirect interests in securities of foreign issuers. Its portfolio consists of securities from Information Technology, Financial, Healthcare, and Industrials among other sectors.